Congratulations to the 96 top-ranking ICIS Student/Postdoc Members 1st author abstract presentations for Cytokines 2022 Hybrid Meeting topics. These trainee travel awards are sponsored by generous gift from the Milstein Family, Vilcek Foundation and ICIS Member donors and are based on the scientific merit of the abstract as well as to enable diversity of participation to include underfunded labs. (Some of the initial travel award winners changed to virtual participation but we still recognize their achievements below).
Spectacular last sunset at Cytokines 2022 / ILC4 going down behind the next generation of cytokine biologists & innate lymphoid cell researchers who will be the ones turning what we know today into promising therapies when the sun comes up tomorrow.
Adrian Achuthan
THE UNIVERSITY OF MELBOURNE, Medicine (Royal Melbourne Hospital)
Parkville, Australia
Presentation: P50 ROLE OF GM-CSF-INDUCED CCL17 IN INFLAMMATION
Daniel Aldridge
University of Pennsylvania, Pathobiology
PHILADELPHIA, United States
Presentation: P51 IL-27 REGULATES MONOPOIESIS AND MONOCYTE FUNCTION DURING ACUTE TOXOPLASMA GONDII INFECTION
Hajera Amatullah
Massachusetts General Hospital,
Boston, United States
Presentation: P53 LOSS OF EPIGENETIC READER SP140 DRIVES CROHN’S DISEASE DUE TO UNCONTROLLED MACROPHAGE TOPOISOMERASES
Laurisa Ankley
Michigan State University, Microbiology and Molecular Genetics
Lansing, United States
Presentation: P54 CHARACTERIZING THE METABOLIC ROLE OF GSK3B IN IFNG-DEPENDENT MACROPHAGE ACTIVATION
Nariaki Asada
University Medical Center Hamburg-Eppendorf, III. Department of Medicine
Hamburg, Germany
Presentation: P77 PRODUCTION OF PROINFLAMMATORY CYTOKINES BY TISSUE RESIDENT MEMORY T CELLS IS REGULATED BY THE INTEGRATED STRESS RESPONSE PATHWAY
Isabel Aschenbrenner
Technical University Munich, Chemistry
Garching, Germany
Presentation: P1 RATIONAL ENGINEERING OF A FOLDING PATHWAY CHANGES MECHANISM AND CHAPERONE DEPENDENCY OF INTERLEUKIN SECRETION
Christopher Basting
University of Minnesota,
Minneapolis, United States
Presentation: P182 INCREASED INFLAMMATION AND GUT BARRIER DAMAGE BIOMARKERS IN HOSPITALIZED PATIENTS WITH SEVERE COVID-19.
Rami Bechara
University of Paris,
Paris, France
Presentation: P22 RNA METHYLATION AND DEMETHYLATION IN IMMUNE/INFLAMMATORY RESPONSES
Julia Blay Cadanet
Aarhus University, Biomedicine
Aarhus, Denmark
Presentation: O1 THE GLUTAMATE-CYSTEINE ANTIPORTER XCT IS IMPORTANT FOR THE CGAS DEPENDENT IFN RESPONSE TO HSV AND CYTOSOLIC DNA
Matthias Bruhn
Twincore Centre For Experimental And Clinical Infection Research (Ulrich Kalinke), Experimental Infection Research
Hannover, Germany
Presentation: O46 MEMORY B CELLS IN SARS-COV-2 CONVALESCENT PATIENTS RE-ENGAGE IN THE IMMUNE RESPONSE AFTER VACCINATION
Haidyn Bulen
The University of Sydney, School of Life and Environmental Sciences
Camperdown, Australia
Presentation: P5 CHARACTERIZATION OF THE COMPLEMENT SYSTEM IN CYTOKINE-DRIVEN NEUROINFLAMMATION
Thomas Burn
University of Melbourne,
Coburg, Australia
Presentation: P80 RUNX3 AND TGFB COLLABORATE TO DRIVE A TISSUE RESIDENCY PROGRAM THAT IS ABSENT IN CD4+ T CELLS
Nicole K Campbell
Hudson Institute of Medical Research, Centre for Innate Immunity and Infectious Diseases
Clayton, Australia
Presentation: P289 INTERFERON EPSILON LIMITS OVARIAN CANCER METASTASIS VIA TUMOUR-EXTRINSIC MECHANISMS
Anthony Cannon
Indiana University, Microbiology and Immunology
Indianapolis, United States
Presentation: P55 TISSUE-SPECIFICITY OF IL-9R-EXPRESSING TUMOR-ASSOCIATED MACROPHAGES
Fangfang Chen
TWINCORE Centre for Experimental and Clinical Infection Research (Frank Pessler), Biomarkers for Infectious Diseases
Hannover, Germany
Presentation: O72 CITRACONATE IMPROVES MITOCHONDRIAL RESPIRATION DURING MACROPHAGE ACTIVATION BY REDUCING ACOD1-MEDIATED ITACONATE SYNTHESIS
Pailin Chiaranunt
University of Toronto, Immunology
Toronto, Canada
Presentation: O99 MICROBIAL ENERGY METABOLISM FUELS A CSF2-DEPENDENT INTESTINAL MACROPHAGE NICHE
Danielle Clancy
VIB-UGent Centre for Inflammation Research,
Ghent, Belgium
Presentation: P82 STRUCTURAL AND FUNCTIONAL INSIGHTS INTO THE ROLE OF THEMIS1 IN T CELL RECEPTOR SIGNALLING
Bibiana Costa
Twincore Centre For Experimental And Clinical Infection Research (Ulrich Kalinke), Experimental Infection Research
Hannover, Germany
Presentation: P84 HCMV EXPLOITS STING SIGNALING AND COUNTERACTS ISG AND IFN-Β, BUT NOT IFN-Λ1 INDUCTION TO FACILITATE VIRAL GENE EXPRESSION IN MONOCYTE-DERIVED DENDRITIC CELLS
Lucy Curham
Trinity College Dublin (Kingston Mills),
Bray, Ireland
Presentation: P204 IL-17-PRODUCING CD4 TISSUE-RESIDENT MEMORY T CELLS MEDIATE PROTECTIVE IMMUNITY AGAINST BORDETELLA PERTUSSIS INFECTION IN THE NASAL MUCOSA
Somayeh Dadras
University of New Mexico, Molecular Genetics & Microbiology
Albuquerque, United States
Presentation: O79 REGULATION OF TAU PATHOLOGY BY THE INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN
Ruby Emily Dawson
Hudson Insitute of Medical Reseach,
Melbourne, Australia
Presentation: P27 THE AIM2 DNA SENSOR PROMOTES GASTRIC INFLAMMATION AND TUMORIGENESIS THROUGH INFLAMMASOME-DEPENDENT AND -INDEPENDENT MECHANISMS
Sushil Dhakal
University of Bergen, Biomedicine
Bergen, Norway
Presentation: P86 AXL INHIBITION ENHANCES TYPE 1 INTERFERON (IFN) RESPONSE AND POTENTIATES CHEMO-IMMUNOTHERAPY
Miqdad Dhariwala
University of California San Francisco,
San Francisco, United States
Presentation: O26 COMMENSAL MYELOID CROSSTALK IN NEONATAL SKIN REGULATES LONG-TERM CUTANEOUS TYPE 17 INFLAMMATION.
Brigette C Duckworth
Walter and Eliza Hall Institute of Medical Research,
Parkville, Australia
Presentation: P88 REVEALING THE FACTORS THAT POSITION MEMORY T CELLS WITHIN SECONDARY LYMPHOID ORGANS
Zachary Earley
University of Chicago (Albert Bendelac and Bana Jabri),
Chicago, United States
Presentation: O55 IGA CONTROLS THE MICROBIOTA FROM DRIVING DYSREGULATED HOST ADAPTIVE IMMUNE RESPONSES
Daniel Enosi Tuipulotu
Australian National University,
Canberra, Australia
Presentation: P292 GUANYLATE-BINDING PROTEINS (GBPS) PROVIDE A HOST-INSPIRED ROADMAP FOR THE DESIGN OF SYNTHETIC ANTIMICROBIAL PEPTIDES
Shouya Feng
The John Curtin School of Medical Research, ANU,
Canberra, Australia
Presentation: P209 INTERFERON-INDUCIBLE GUANYLATE-BINDING PROTEINS CONTRIBUTE TO BACTERIAL SPECIFIC RECOGNITION AND HOST INFLAMMATION
Matthias Friedrich
University of Oxford,
Oxford, United Kingdom
Presentation: O81 CYTOKINE-INDUCED EPIGENETIC REWIRING OF PATHOGENIC FIBROBLASTS IN PATIENTS WITH CROHNS DISEASE
Ka Yee Fung
Walter&Eliza Hall Institute Medical Reseach,
Parkville, Australia
Presentation: INTERLEUKIN-11 PRODUCED BY MYELOID CELLS DRIVES AUTOIMMUNE DISEASE PATHOLOGY
Liraz Galia
UMass Chan medical school, Department of Medicine
shrewsbury, United States
Presentation: O89 A NEWLY IDENTIFIED TRANSCRIPT OF THE LNCRNA, HOXA11OS, PROMOTES GUT HOMEOSTASIS THROUGH REGULATION OF IMMUNOMETABOLISM
Dominic Golec
NIH (Pamela Schwartzberg),
Washington, United States
Presentation: O92 PI3K-DELTA SHAPES TH1 AND TH2 IDENTITY THROUGH COORDINATION OF IL-2 SIGNALING, FOXO1 INACTIVATION AND EPIGENETIC REMODELING
Adrian Gomez-Nguyen
Case Western Reserve University,
Cleveland, United States
Presentation: O45 PSYCHOLOGICAL STRESS PROMOTES COLONIC TERTIARY LYMPHOID ORGAN FORMATION THROUGH IL-23 SIGNALING AND CONFERS PROTECTION AGAINST SECONDARY INJURY
Trever T Greene
University Of California San Diego (Elina Zuniga),
San Diego, United States
Presentation: O22 TYPE I INTERFERON EXHAUSTION IN PLASMACYTOID DENDRITIC CELLS: UNDERLYING MECHANISM AND POTENTIAL BENEFIT.
Rahul Gupta
Department of Microbiology and Immunology, Stony Brook University
Stony Brook, USA
Presentation: P9 EARLY IL-1 BLOCKING: GAMECHANGER IN COVID-19?
Anne Louise Hansen
Aarhus University, Department of Biomedicine
Aarhus, Denmark
Presentation: P32 A NITROALKENE COMPOUND SCREEN FOR INHIBITORS OF STING-DEPENDENT INFFLAMMATION
Emina Hayashida
The University of Sydney, School of Life and Environmental Sciences (SOLES)
Sydney, Australia
Presentation: P126 ABLATING IFN-I RESPONSES IN ASTROCYTES IS PROTECTIVE IN A MOUSE MODEL OF IFN-ALPHA-MEDIATED NEUROTOXICITY
Stuart Taliesin Owain Hughes
Cardiff University,
Cardiff, United Kingdom
Presentation: P128 EXPLORING SYNOVITIS’ HETEROGENEITY THROUGH NEXT GENERATION SEQUENCING
Yung Jin Jeon
Gyeongsang National University Hospital, Department of Otorhinolaryngology
Jinju, Korea, Republic Of
Presentation: P186 NASAL MICROBIOME STAPHYLOCOCCUS EPIDERMIDIS LIMITS IL-33 PRODUCTION IN ALLERGIC NASAL MUCOSA BY REGULATING RIPK3-MLKL-MEDIATED NECROPTOSIS
Tristan X Jordan
NYU Grossman School of Medicine, Microbiology
New York, United States
Presentation: P218 REGULATING BASELINE ACTIVATION OF THE IFN-I RESPONSE
Vaishnavi Kaipilyawar
Rutgers New Jersey Medical School, Medicine
Newark, United States
Presentation: P220 MECHANISMS REGULATING GRANULOMA DEVELOPMENT AND HETEROGENEITY IN HIGH- AND LOW-TRANSMISSION MYCOBACTERIUM TUBERCULOSIS INFECTIONS
Sevasti Karaliota
National Cancer Institute at Frederick (NCI/NIH) (George Pavlakis), Human Retrovirus Section, Vaccine Branch, Center for Cancer Research
Frederick, United States
Presentation: O73 HETERODIMERIC IL-15 (HETIL-15) IMMUNOTHERAPY SYNERGIZES WITH A FATTY ACID METABOLISM MODULATOR, REVERSING THE METABOLIC DYSFUNCTION OF TUMOR INFILTRATING CD8+T CELLS AND LEADING TO TUMOR ERADICATION IN TNBC MOUSE MODEL
Narelle Keating
The Walter and Eliza Hall Institute of Medical Research,
Parkville, Australia
Presentation: O28 ARAP2 IS A POSITIVE REGULATOR OF THE IFN-GAMMA RESPONSE
Cody Kempen
Stony Brook University, Microbiology & Immunology
Deer Park, United States
Presentation: O58 INTERLEUKIN-17 RECEPTOR SIGNALING PROMOTES PANETH CELL STEMNESS AND THEIR ABILITY TO REGENERATE GUT EPITHELIUM AFTER IRRADIATION INDUCED INJURY
Piotr Konieczny
NYU Langone Health, Department of Pathology
New York, United States
Presentation: P262 INTERLEUKIN-17 GOVERNS HYPOXIC ADAPTATION OF INJURED EPITHELIUM
Justina Kulikauskaite
Francis Crick Instittute,
London, United Kingdom
Presentation: P60 INFLUENZA-INDUCED HOST DEFENSE AGAINST BACTERIAL INFECTIONS BY MONOCYTE-DERIVED ALVEOLAR MACROPHAGES AND NEUTROPHILS
Charlotte M Leane
Trinity College Dublin (Kingston Mills),
Dublin 2, Ireland
Presentation: P283 IL-17A-SECRETING ΓΔ T CELLS ARE REGULATED BY PD-1 IN A MODEL OF CENTRAL NERVOUS SYTEM AUTOIMMUNITY
Yang Li
University of Pittsburgh, Department of medicine
Pittsburgh, United States
Presentation: O90 THE RNA BINDING PROTEIN ARID5A MEDIATES IL-17 SIGNALING AND DISEASE PATHOGENESIS IN AUTOIMMUNE GLOMERULONEPHRITIS
Chia-Hao Lin
University of California San Diego (Li-Fan Lu),
San Diego, United States
Presentation: P97 SELECTIVE IL-27 PRODUCTION BY INTESTINAL REGULATORY T CELLS PERMITS GUT-SPECIFIC REGULATION OF TH17 IMMUNITY
Enkhmaa Lkhagva-yondon
Inha University,
Incheon, Korea, Republic Of
Presentation: P98 ARYL HYDROCARBON RECEPTOR PROMOTES INDUCIBLE NITRIC OXIDE PROTEIN BY REGULATING EUKARYOTIC ELONGATION FACTOR-2 KINASE UBIQUITINATION
Juliane Lokau
Otto-von-Guericke University Magdeburg, Department of Pathology
Magdeburg, Germany
Presentation: P99 SOLUBLE IL-2RΑ/CD25 IS GENERATED BY THE METALLOPROTEASES ADAM10 AND ADAM17
Saikat Majumder
University of Pittsburgh,
Pittsburgh, United States
Presentation: P131 IL-17 PROTECTS AGAINST HYPERACTIVATION AND EXHAUSTION BY REGULATING IFN-GAMMA DURING CHRONIC VIRAL INFECTION
Thomas H. Mann
Salk Institute for Biological Studies, NOMIS Center for Immunobiology and Microbial Pathogenesis
La Jolla, United States
Presentation: P100 DISCOVERY OF A MOLECULAR CLOCK THAT CONTROLS CD8+ T CELL FUNCTION AND EXHAUSTION
Aslan Mansurov
University of Chicago (Jeffrey Hubbell), Pritkzer School of Molecular Engineering
Chicago, United States
Presentation: O32 ELIMINATING THE IMMUNOTOXICITY OF INTERLEUKIN-12 THROUGH PROTEASE-SENSITIVE MASKING
Iva Marković
VIB-UGent Center for Inflammation Research, Unit for Structural Biology
Gent, Belgium
Presentation: P36 CAUGHT IN THE ACT: NOVEL TSLP NANOTOOLS FOR STRUCTURE-FUNCTION STUDIES.
Anukriti Mathur
Australian National University, Department of Immunology and Infectious Disease, The John Curtin School of Medical Research
Canberra, Australia
Presentation: O9 A BACTERIAL LECITHINASE SHAPES THE INFLAMMATORY LANDSCAPE VIA ACTIVATION OF THE NLRP3 INFLAMMASOME
Rina Matsuda
University of Pennsylvania,
Philadelphia, United States
Presentation: P227 INFLAMMATORY MONOCYTES PROMOTE PYOGRANULOMA FORMATION TO COUNTERACT YERSINIA BLOCKADE OF HOST DEFENSE
Louise McLeod
Hudson Institute of Medical Research, Centre for Innate Immunity & Infectious Disease
Clayton, Australia
Presentation: P38 CROSS-TALK BETWEEN IL-6 TRANS-SIGNALLING AND AIM2 INFLAMMASOME/IL-1Β AXES BRIDGE INNATE IMMUNITY AND EPITHELIAL APOPTOSIS TO PROMOTE EMPHYSEMA
Emily V Mesev
Princeton University,
PRINCETON, United States
Presentation: P40 INTRACELLULAR DOMAINS OF TYPE I AND III INTERFERON RECEPTORS ENCODE DIFFERENCES IN JAK-STAT SIGNALING MAGNITUDE
Simone A Minnie
Fred Hutchinson Cancer Research Center, Clinical Research Division
Seattle, United States
Presentation: O35 DECOY RESISTANT IL-18 EXPANDS HIGHLY FUNCTIONAL C-MAF+ CD8 T CELLS IN THE BONE MARROW TUMOR MICROENVIRONMENT
Fei Mo
NIH (Warren J. Leonard),
Bethesda, United States
Presentation: P301 AN ENGINEERED IL-2 PARTIAL AGONIST PROMOTES CD8+ T CELL STEMNESS
Mays Mohammed Salih
UC Santa Cruz,
San Jose, United States
Presentation: P135 DETERMINING HNRNP-A2/B1’S ROLE IN INFLAMMATION AND RHEUMATOID ARTHRITIS PATHOLOGY
Hiroyuki Nagashima
NIH (John O’Shea), NIAMS
Bethesda, United States
Presentation: O52 DISTINCT 3D REMODELING OF IL4-IL13-IL5 LOCI MEDIATES DIFFERENTIAL TYPE 2 RESPONSES IN INNATE VERSUS ADAPTIVE LYMPHOCYTES
Hyo Jeong Nam
Seoul National University,
Seoul, Korea, Republic Of
Presentation: P285 SPATIAL MOLECULAR DIAGNOSIS OF PSORIASIS AND ATOPIC DERMATITIS TISSUE DEFINES A NEW DISEASE SUBSET: TH2 PSORIASIS
Neha Nataraj
Perelman School of Medicine at the University of Pennsylvania,
Philadelphia, United States
Presentation: P230 RIPK1 IS DISPENSABLE FOR APOPTOSIS IN HUMAN MACROPHAGES IN RESPONSE TO YERSINIA BLOCKADE OF IMMUNE SIGNALING
Brian Orcutt-Jahns
University of California, Los Angeles, Bioengineering
Los Angeles, United States
Presentation: P44 MULTIVALENCY ENHANCES THE SPECIFICITY OF FC-CYTOKINE FUSIONS
Andreas Pavlou
Twincore (Ulrich Kalinke),
Hannover, Germany
Presentation: P233 MAVS SIGNALING OF MICROGLIA IS CRITICALLY NEEDED TO DEFINE THE TRANSCRIPTIONAL STATUS OF CNS INFILTRATING CD8+ T CELLS IN VIRAL ENCEPHALITIS
Philipp Penninger
Medical University of Vienna, Center for Medical Biochemistry, Division of Molecular Genetics
Vienna, Austria
Presentation: O57 HISTONE DEACETYLASE 1 RESTRICTS PRO-INFLAMMATORY CYTOKINE RELEASE IN T CELL-MEDIATED ANTIFUNGAL IMMUNITY
Anthony Phan
University of Pennsylvania, Pathobiology
Philadelphia, United States
Presentation: P102 LIPID NANOPARTICLE INDUCED IL-27 PROMOTES VACCINE ELICITED MEMORY CD8+ T CELLS
Rachael Philips
NIH (John O’Shea), NIH
Bethesda, United States
Presentation: O3 STAT1 GAIN OF FUNCTION MUTATION IMPAIRS IMMUNE RESPONSE TO VIRAL INFECTIONS
Gabriela A. Pizzurro
Yale University, Biomedical Engineering
New Haven, United States
Presentation: O31 CD40-AGONIST TREATMENT CAN REVERSE CHECKPOINT INHIBITOR RESISTANCE IN MELANOMA VIA PRIMING THE INFLAMMATORY RESPONSE OF MACROPHAGES
Nicole O. Ponde
University of Pittsburgh, Department of Medicine, Division of Rheumatology & Clinical Immunology
Pittsburgh, United States
Presentation: P66 AN UNLIKELY PAIRING: A ROLE FOR IL-17 IN SARS-COV2 ORF8-INDUCED MACROPHAGE ACTIVATION?
Haressh Sajiir
Mater Research Institute – UQ, Immunopathology
Brisbane, Australia
Presentation: O19 A NOVEL ROLE FOR ENDOGENOUS PANCREATIC BETA CELL IL-22 SIGNALING IN MAINTAINING SYSTEMIC METABOLIC HOMEOSTASIS
Kishan Sangani
University of Chicago (Bana Jabri),
Chicago, United States
Presentation: P105 TET2 IS A CELL INTRINSIC REGULATOR FOR INTESTINAL TH2 IMMUNITY
Myeongseong Seo
Inha University,
Incheon, Korea, Republic Of
Presentation: P107 NEURONS CAN INHIBIT THE ACTIVATION OF T CELLS VIA REGULATING THE TGF-ß PATHWAYS
Deepika Sharma
University of Chicago (Bana Jabri), Department of Medicine
Chicago, United States
Presentation: P270 DNA DEMETHYLASE TET2 MEDIATES EPITHELIAL-IMMUNE CROSSTALK DURING COLON TUMORIGENESIS
Jorna Sojati
University of Pittsburgh School of Medicine, Pediatrics
Pittsburgh, United States
Presentation: O66 TYPE I AND III INTERFERON DRIVE NON-REDUNDANT AND AIRWAY SITE-SPECIFIC ANTIVIRAL IMMUNE RESPONSES IN HUMAN METAPNEUMOVIRUS INFECTION
Atri Ta
UConn Health, Immunology
West Hartford, United States
Presentation: O64 A BACTERIAL AUTOTRANSPORTER IMPAIRS INNATE IMMUNE RESPONSES BY TARGETING THE TRANSCRIPTION FACTOR TFE3
Ka Man Tse
Kyoto University,
Kyoto, Japan
Presentation: P306 DAMPENING INFLAMMATION BY ENHANCING REGNASE-1 EXPRESSION WITH STEM-LOOP-TARGETING MORPHOLINO OLIGONUCLEOTIDES
Derek VanDyke
Johns Hopkins University, Chemical and Biomolecular Engineering
Baltimore, United States
Presentation: P308 ENGINEERING A CYTOKINE/ANTIBODY FUSION PROTEIN THAT SELECTIVELY EXPANDS REULATORY T CELLS AND CONFERS PROTECTION AGAINST AUTOIMMUNE DISEASES
Sebastian Krause
University of Nottingham Queens Med Ctr,
Nottingham, United Kingdom
Presentation: O13 FAMILY-WIDE IDENTIFICATION OF LATENT STAT DIMERS IN LIVING CELLS
Yaqiu Wang
St. Jude Children’s Research Hospital,
MEMPHIS, United States
Presentation: P249 CASPASE-8–CASPASE-3 AXIS INHIBITS CYTOKINE RELEASE BY INACTIVATING GSDMD DURING INFECTIONS
Hauke J Weiss
Trinity College Dublin (Luke O’Neill), Biochemistry
Dublin, Ireland
Presentation: P251 4-OCTYL ITACONATE REDUCES INFLUENZA A REPLICATION BY TARGETING THE NUCLEAR EXPORT PROTEIN CRM1
Alexandria Wells
NIAID/NIH (Yasmine Belkaid),
Washington, United States
Presentation: O88 ROLE OF ENDOGENOUS RETROVIRUSES IN THE CONTROL OF TISSUE THRESHOLD OF ACTIVATION AND RESPONSES TO THE MICROBIOTA
Cody L. Wolf
Boise State University, Biomolecular Sciences Program
Boise, United States
Presentation: O33 NOVEL SMALL MOLECULAR INHIBITORS AS POSSIBLE TARGETED THERAPEUTICS FOR BREAST CANCER METASTASIS
Austin Paul Wright
Oregon Health and Science University, Molecular Microbiology and Immunology
Portland, United States
Presentation: P189 CRISPR SCREENS IDENTIFY INTERFERON REGULATORY FACTOR 6 AS A POTENTIAL REGULATOR OF INTERFERON SIGNALING IN THE INTESTINAL EPITHELIUM
Hongxu Xian
UCSD (Michael Karin),
San Diego, United States
Presentation: P72 FEN1-GENERATED OXIDIZED DNA FRAGMENTS ESCAPE MITOCHONDRIA VIA MPTP- AND VDAC-DEPENDENT CHANNELS TO LICENSE NLRP3 INFLAMMASOME AND STING ACTIVATION
Ziyan Xu
Salk Institute for Biological Studies/UCSD,
La Jolla, United States
Presentation: P73 SCAVENGER RECEPTOR CD36 REGULATES INFLAMMATORY AND TYPE-I INTERFERON RESPONSES IN TUMOR-ASSOCIATED MACROPHAGES
Olha Yaroshko
Institute of Cell Biology and Genetic Engineering National Academy of Science of Ukraine, Institute of Cell Biology and Genetic Engineering National Academy of Science of Ukraine
Kyiv, Ukraine
Presentation: P320 ORAL ADMINISTRATION OF TRANSGENIC HUIFN-CONTAINING TOMATOES ALTERS THE CYTOKINE PROFILE AND ENSURES THE SURVIVAL OF VSV-INFECTED BALB/C MICE
Wen Zhang
Weill Cornell Medicine,
New York, United States
Presentation: P272 GUT-INNERVATING NOCICEPTORS REGULATE THE INTESTINAL MICROBIOTA TO PROMOTE TISSUE PROTECTION
Jenna Zhang
University of Pennsylvania Perelman School of Medicine,
Philadelphia, United States
Presentation: P253 YERSINIA TYPE III-SECRETED EFFECTORS EVADE HUMAN CASPASE-4-DEPENDENT INFLAMMASOME ACTIVATION IN INTESTINAL EPITHELIAL CELL